SYBE Share Price Performance
US$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
SYBE Community Narratives
There are no narratives available yet.
Recent SYBE News & Updates
Sybleu Inc. Key Details
Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.029
- Gross Margin
- 100.00%
- Net Profit Margin
- -2,632.19%
- Debt/Equity Ratio
- -125.3%
Sybleu Inc. Competitors
Snowflake Analysis
About SYBE
- Founded
- 2020
- Employees
- n/a
- CEO
- Website
SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications. It develops medical applications up to the point of completion of Phase I and or Phase II clinical trials after which the company sell or license developed applications or advance the application to Phase III clinical trials. SYBLEU INC. was incorporated in 2020 and is based in Bronx, New York. As of April 15, 2024, Sybleu Inc. operates as a subsidiary of Worldwide Holdings, LLC.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
U.S. Market Performance
- 7 Days: 0.5%
- 3 Months: 11.7%
- 1 Year: 15.7%
- Year to Date: 10.1%
The market has been flat over the last week. More promisingly, the market is up 16% over the past year. Earnings are forecast to grow by 15% annually. Market details ›